a 2015

Capizzi methotrexate with BFM backbone without craniospinal irradiation is effective treatment for pediatric lymphoblastic lymphoma: results from 5 countries with I-BFM LL 09 protocol

ŠTĚRBA, Jaroslav, Gabor KOVACS, Monica MATUS, Eva BUBANSKA, Michal KÝR et. al.

Basic information

Original name

Capizzi methotrexate with BFM backbone without craniospinal irradiation is effective treatment for pediatric lymphoblastic lymphoma: results from 5 countries with I-BFM LL 09 protocol

Authors

ŠTĚRBA, Jaroslav (203 Czech Republic, guarantor, belonging to the institution), Gabor KOVACS (348 Hungary), Monica MATUS (32 Argentina), Eva BUBANSKA (703 Slovakia), Michal KÝR (203 Czech Republic, belonging to the institution), Zdenka KŘENOVÁ (203 Czech Republic, belonging to the institution) and Owen SMITH (372 Ireland)

Edition

Fifth International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma, 2015

Other information

Language

English

Type of outcome

Konferenční abstrakt

Field of Study

30200 3.2 Clinical medicine

Country of publisher

Italy

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 5.812

RIV identification code

RIV/00216224:14110/15:00084951

Organization unit

Faculty of Medicine

ISSN

Keywords in English

Lymphoblastic lymphoma; Non-Hodgkin lymphomas

Tags

Změněno: 27/11/2015 12:59, Ing. Mgr. Věra Pospíšilíková

Abstract

V originále

Lymphoblastic lymphoma represents 20% of all pediatric Non-Hodgkin lymphomas. The outcome of patients with LL has not improved during the last two decades, both due to disease progressions and treatment-related toxicity.